The 2026 ESMO annual meeting featured a rapid oral session and a discussant presentation by Dr. Alison Reid discussing three ...
(UroToday.com) The 2026 European Society of Medical Oncology (ESMO) Annual Congress held the session: Genitourinary tumour, ...
This analysis included 58 patients treated with gemcitabine intravesical system monotherapy in the SunRISe-1 cohort who had ...
(UroToday.com) The 2026 North Central Section of the AUA annual meeting featured a prostate cancer session and a presentation ...
The 2026 North Central Section of the AUA annual meeting featured a urothelial carcinoma session and a presentation by Dr.
The 2026 North Central Section of the AUA annual meeting featured a bladder cancer session and a presentation by Dr. Kaitlin Davis discussing regional disparities in bladder cancer mortality rates.
Daniel Spratt and Alicia Morgans discuss clinical outcomes of patients with Gleason score 9-10 prostate cancer after definitive treatment. Long-term Survival in Men with Gleason Score 9-10 Treated ...
NCS AUA 2026: The Germline Mutational Landscape and Survival Outcomes of Upper Tract Urothelial Carcinoma ...
Conventional prognostic models for metastatic prostate cancer (mPC) typically rely on summary features like prostate-specific antigen (PSA) doubling time, often obscuring informative longitudinal ...
Renal cell carcinoma (RCC) comprises approximately 90% of malignancy in the kidney. Early stage RCC is often asymptomatic. The majority of RCC are incidentally found on imaging ordered for unrelated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results